Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 71.8%

Neg 0% Neu 0% Pos 71.8%

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $100.